Cargando…

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach

Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypogl...

Descripción completa

Detalles Bibliográficos
Autor principal: Kedia, Nitil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180523/
https://www.ncbi.nlm.nih.gov/pubmed/21969805
http://dx.doi.org/10.2147/DMSO.S20633
_version_ 1782212656001712128
author Kedia, Nitil
author_facet Kedia, Nitil
author_sort Kedia, Nitil
collection PubMed
description Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypoglycemia. Available as an emergency kit, glucagon is an essential tool for rapid response, but remains underappreciated and underused. This article reviews the role of glucagon in treating severe hypoglycemia and discusses the need for better education on glucagon for people with diabetes and their caregivers in order to alleviate fears of hypoglycemia and of administering glucagon in the event of an emergency.
format Online
Article
Text
id pubmed-3180523
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31805232011-10-03 Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach Kedia, Nitil Diabetes Metab Syndr Obes Review Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypoglycemia. Available as an emergency kit, glucagon is an essential tool for rapid response, but remains underappreciated and underused. This article reviews the role of glucagon in treating severe hypoglycemia and discusses the need for better education on glucagon for people with diabetes and their caregivers in order to alleviate fears of hypoglycemia and of administering glucagon in the event of an emergency. Dove Medical Press 2011-09-06 /pmc/articles/PMC3180523/ /pubmed/21969805 http://dx.doi.org/10.2147/DMSO.S20633 Text en © 2011 Kedia, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Kedia, Nitil
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
title Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
title_full Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
title_fullStr Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
title_full_unstemmed Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
title_short Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
title_sort treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180523/
https://www.ncbi.nlm.nih.gov/pubmed/21969805
http://dx.doi.org/10.2147/DMSO.S20633
work_keys_str_mv AT kedianitil treatmentofseverediabetichypoglycemiawithglucagonanunderutilizedtherapeuticapproach